Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
about
Early biomarkers of joint damage in rheumatoid and psoriatic arthritisRole of IL-33 and its receptor in T cell-mediated autoimmune diseasesActivated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis.Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells.Role of IL-33 in inflammation and disease.Pathways for bone loss in inflammatory disease.Mast Cells Respond to Cell Injury through the Recognition of IL-33.The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.Emerging role of interleukin-33 in autoimmune diseases.Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells.Interleukin-33: increasing role in dermatological conditions.Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts.Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells.IL-33 neutralization suppresses lupus disease in lupus-prone mice.The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members.Potential role of the IL-33/ST2 axis in celiac disease.Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune ResponsesThe Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
P2860
Q28083506-35B6818E-B2E2-4DE0-A229-E0B3DD6291C6Q33854499-7EA41154-C5ED-4A45-989A-07E25107B0CEQ36744984-BBA474F6-056F-488C-B9AD-4CD7F3BE415CQ36903150-0C784131-CBF7-4582-9F61-B8DCA63451D0Q37196901-BB0188A7-D5AF-466D-AC4B-DDA629323961Q37198846-C1A4DE04-18B8-409B-8EDB-829D136FA037Q37728065-E4C6B046-15F3-47DD-9208-AD63EAB31D8AQ37922810-0D0C68D0-D555-4931-896D-366FF20E334DQ38004935-03B0E8D6-3527-432A-BB18-DFCB26D08ED9Q38008374-42ACED5A-D872-441F-9E11-2E59A80E6E57Q38068933-0115E409-FFDE-4688-A0FD-4E7F195E15AAQ38151715-933635F9-E90A-4D6F-BDA8-0949E41213ECQ38764557-65E3DF65-E147-4B8C-B282-AE1DE3495B6CQ38770982-248691F3-53D6-4143-ACF0-8714821A5F35Q39406925-9AEA7875-7CA1-4F02-AAB7-439021057711Q48272507-5FE143DF-E7BA-4985-9569-8746F883B5EEQ49831974-2E742955-6D99-4560-A33B-28C7FBE62092Q52678075-6679D0F3-55B8-49ED-B72E-A5447ECF1262Q54323094-B05E54C4-C02A-4DCA-B224-607EEF5F5FF0Q54688502-E2EFFFF4-460E-4D53-A739-1BF4E3F0499AQ54960727-9DAB9098-71C9-47DE-9121-16416B9C4824Q58234722-CCC4762F-305A-4B43-BFF3-25826FDA39D4Q58707724-237CE252-7007-4063-93C5-FB2911F4CEB5
P2860
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@en
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@nl
type
label
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@en
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@nl
prefLabel
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@en
Distinct serum and synovial fl ...... arthritis and osteoarthritis.
@nl
P2093
P1433
P1476
Distinct serum and synovial fl ...... c arthritis and osteoarthritis
@en
P2093
Dominique L Baeten
Dominique Talabot-Ayer
Patrizia Gindre
Sylvette Bas
P356
10.1016/J.JBSPIN.2011.02.011
P577
2011-03-26T00:00:00Z